Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1986 1
1987 2
1988 3
1989 2
1990 2
1992 3
1993 2
1994 1
1995 3
1996 2
1997 1
1998 2
1999 2
2000 1
2001 4
2002 4
2003 1
2004 4
2006 4
2007 4
2008 5
2009 5
2010 3
2011 3
2012 1
2013 3
2014 10
2015 5
2016 5
2017 6
2018 6
2019 6
2020 5
2021 4
2022 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

108 results

Results by year

Filters applied: . Clear all
Page 1
Chronic neutrophilic leukemia: 2020 update on diagnosis, molecular genetics, prognosis, and management.
Szuber N, Elliott M, Tefferi A. Szuber N, et al. Am J Hematol. 2020 Feb;95(2):212-224. doi: 10.1002/ajh.25688. Epub 2019 Dec 30. Am J Hematol. 2020. PMID: 31769070 Free article. Review.
DISEASE OVERVIEW: Chronic neutrophilic leukemia (CNL) is a rare, often aggressive myeloproliferative neoplasm (MPN) defined by persistent mature neutrophilic leukocytosis, bone marrow granulocyte hyperplasia, and frequent hepatosplenomegaly. ...
DISEASE OVERVIEW: Chronic neutrophilic leukemia (CNL) is a rare, often aggressive myeloproliferative neoplasm (MPN) def …
Dermatological Toxicities of Bruton's Tyrosine Kinase Inhibitors.
Sibaud V, Beylot-Barry M, Protin C, Vigarios E, Recher C, Ysebaert L. Sibaud V, et al. Am J Clin Dermatol. 2020 Dec;21(6):799-812. doi: 10.1007/s40257-020-00535-x. Am J Clin Dermatol. 2020. PMID: 32613545 Review.
The development of Bruton's tyrosine kinase (BTK) inhibitors represents a major breakthrough in the treatment of chronic lymphocytic leukemia and other B cell malignancies. The first-generation inhibitor ibrutinib works by covalent irreversible binding to BTK, a non …
The development of Bruton's tyrosine kinase (BTK) inhibitors represents a major breakthrough in the treatment of chronic lymphocytic …
Chronic neutrophilic leukaemia.
Uppal G, Gong J. Uppal G, et al. J Clin Pathol. 2015 Sep;68(9):680-4. doi: 10.1136/jclinpath-2015-203060. Epub 2015 Jun 16. J Clin Pathol. 2015. PMID: 26082513 Review.
Chronic neutrophilic leukaemia (CNL) is a rare type of myeloproliferative neoplasm (MPN) characterised by sustained leucocytosis (2510(9)/L) with neoplastic proliferation of neutrophilic granulocytes in blood and bone marrow. In contrast to chronic …
Chronic neutrophilic leukaemia (CNL) is a rare type of myeloproliferative neoplasm (MPN) characterised by sustained leu …
Chronic Neutrophilic Leukemia: Current and Future Perspectives.
Venugopal S, Mascarenhas J. Venugopal S, et al. Clin Lymphoma Myeloma Leuk. 2019 Mar;19(3):129-134. doi: 10.1016/j.clml.2018.11.012. Epub 2018 Nov 29. Clin Lymphoma Myeloma Leuk. 2019. PMID: 30581159 Review.
Chronic neutrophilic leukemia (CNL) is a BCR-ABL1-negative myeloproliferative neoplasm with notably dismal survival. ...
Chronic neutrophilic leukemia (CNL) is a BCR-ABL1-negative myeloproliferative neoplasm with notably dismal survival. .. …
Genomics of chronic neutrophilic leukemia.
Maxson JE, Tyner JW. Maxson JE, et al. Blood. 2017 Feb 9;129(6):715-722. doi: 10.1182/blood-2016-10-695981. Epub 2016 Dec 27. Blood. 2017. PMID: 28028025 Free PMC article. Review.
Chronic neutrophilic leukemia (CNL) is a distinct myeloproliferative neoplasm with a high prevalence (>80%) of mutations in the colony-stimulating factor 3 receptor (CSF3R). ...However, recent additional genomic characterization demonstrates that CNL has m …
Chronic neutrophilic leukemia (CNL) is a distinct myeloproliferative neoplasm with a high prevalence (>80%) of mutat …
Current Management of Chronic Neutrophilic Leukemia.
Szuber N, Tefferi A. Szuber N, et al. Curr Treat Options Oncol. 2021 Jun 7;22(7):59. doi: 10.1007/s11864-021-00856-x. Curr Treat Options Oncol. 2021. PMID: 34097138 Review.
Chronic neutrophilic leukemia (CNL) is a rare myeloproliferative neoplasm (MPN) characterized by oncogenic driver mutations in colony-stimulating factor 3 receptor (CSF3R). ...
Chronic neutrophilic leukemia (CNL) is a rare myeloproliferative neoplasm (MPN) characterized by oncogenic driver mutat …
Chronic neutrophilic leukemia: new science and new diagnostic criteria.
Szuber N, Tefferi A. Szuber N, et al. Blood Cancer J. 2018 Feb 13;8(2):19. doi: 10.1038/s41408-018-0049-8. Blood Cancer J. 2018. PMID: 29440636 Free PMC article. Review.
Chronic neutrophilic leukemia (CNL) is a distinct myeloproliferative neoplasm defined by persistent, predominantly mature neutrophil proliferation, marrow granulocyte hyperplasia, and frequent splenomegaly. ...
Chronic neutrophilic leukemia (CNL) is a distinct myeloproliferative neoplasm defined by persistent, predominantly matu …
Recent Progress in Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia.
Dao KT, Tyner JW, Gotlib J. Dao KT, et al. Curr Hematol Malig Rep. 2017 Oct;12(5):432-441. doi: 10.1007/s11899-017-0413-y. Curr Hematol Malig Rep. 2017. PMID: 28983816 Review.
PURPOSE OF REVIEW: We reviewed recent diagnostic and therapeutic progress in chronic neutrophilic leukemia (CNL) and atypical chronic myeloid leukemia (aCML). ...
PURPOSE OF REVIEW: We reviewed recent diagnostic and therapeutic progress in chronic neutrophilic leukemia (CNL) and at …
Advances in molecular evaluation of myeloproliferative neoplasms.
Li N, Chen M, Yin CC. Li N, et al. Semin Diagn Pathol. 2023 May;40(3):187-194. doi: 10.1053/j.semdp.2023.04.007. Epub 2023 Apr 13. Semin Diagn Pathol. 2023. PMID: 37087305 Review.
Without appropriate management, the natural history of most MPN consists of an initial chronic phase and a terminal blast phase. Molecular aberrations involving protein tyrosine kinases have been used for the diagnosis, classification, detection of minimal/measurable resid …
Without appropriate management, the natural history of most MPN consists of an initial chronic phase and a terminal blast phase. Mole …
Chronic neutrophilic leukemia: novel mutations and their impact on clinical practice.
Tefferi A, Elliott M, Pardanani A. Tefferi A, et al. Curr Opin Hematol. 2015 Mar;22(2):171-6. doi: 10.1097/MOH.0000000000000114. Curr Opin Hematol. 2015. PMID: 25575036 Review.
PURPOSE OF REVIEW: Chronic neutrophilic leukemia (CNL) is a rare BCR-ABL1-negative myeloid malignancy that is characterized by mature granulocytosis without dysgranulopoiesis. Differential diagnosis of CNL includes reactive or secondary granulocytosis and oth …
PURPOSE OF REVIEW: Chronic neutrophilic leukemia (CNL) is a rare BCR-ABL1-negative myeloid malignancy that is character …
108 results